 |
 |
 |
|
 |
|
 |
|
 |
 |
||
 |
Dr. Bilenker serves as a Principal
of Aisling Capital. Previously, Dr. Bilenker was a
Medical Officer in the Office of Oncology Drug Products
at the U.S. Food and Drug Administration. While at the
FDA, he conducted clinical reviews of IND-stage and
licensed biologic oncology products. Prior to joining
the FDA, Dr. Bilenker trained at the University of
Pennsylvania in internal medicine and medical oncology,
earning board certification in these specialties. |
Dennis Purcell |
